873191-23-2

Basic information

• Product Name: 5-Bromomethyl-1,3-dimethyl-1H-pyrazole
• Synonyms: 5-Bromomethyl-1,3-dimethyl-1H-pyrazole
• CAS NO: 873191-23-2
• Molecular Formula: C₆H₉BrN₂
• Molecular Weight: 189.05306
• Mol File: 873191-23-2.mol

Chemical Properties

• Boiling Point: 239.1±25.0 °C(Predicted)
• Appearance: /
• Density: 1.49±0.1 g/cm3(Predicted)
• PKA: 2.17±0.10(Predicted)
• CAS DataBase Reference: 5-Bromomethyl-1,3-dimethyl-1H-pyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromomethyl-1,3-dimethyl-1H-pyrazole(873191-23-2)
• EPA Substance Registry System: 5-Bromomethyl-1,3-dimethyl-1H-pyrazole(873191-23-2)

Safety Data

• Statements: 22
• Safety Statements: 24/25
• RIDADR: 2811
• Hazardous Substances Data: 873191-23-2(Hazardous Substances Data)

Usage

Chemical Properties

Off-white solid

Upstream product

• 57012-20-1 (1,3-dimethyl-1H-pyrazol-5-yl)methanol 

Relevant articles and documents

OREXIN RECEPTOR ANTAGONISTS

The disclosures herein relate to novel compounds of formula wherein W, X and Y1, Y2, Y3 and Y4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.

USE OF PYRROLO [2 , 3-B] PYRIDINES TO PREPARE A MEDICAMENT FOR TREATING PAIN

There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use in the manufacture of a medicament for the treatment of neuropathic pain.

FUSED PYRIMIDINE DERIVATIVES AND COMPOSITIONS THEREOF AS CXCR3 RECEPTOR MODULATORS, USEFUL IN PREVENTION AND TREATMENT OF INFLAMMATORY AND IMMUNOREGULATORY DISORDERS AND DISEASES

Compounds are provided having the formula: wherein variables Ra, R1, R2, R3, R4, A1, A4, L, Q, X and subscript n as described herein. The subject compounds are useful for treatment of inflammatory and immune conditions and diseases. Compositions and methods of treatment using the subject compounds are also provided. For example, the subject methods are useful for treatment of inflammatory and immune disorders and disease such as multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

TETRAHYDROQUINAZOLIN-4(3H)-ONE-RELATED AND TETRAHYDROPYRIDO[2,3-D]PYRIMIDIN-4(3H)-ONE-RELATED COMPOUNDS, COMPOSITIONS AND METHODS FOR THEIR USE

Compounds are provided having the formula (I) wherein variables A1, A2, A3, A4, R1, R2, R3, R4, Q and L are described herein. The subject compounds are useful for treatment of inflammatory and immune conditions and diseases. Compositions and methods of treatment using the subject compounds are also provided. For example, the subject methods are useful for treatment of inflammatory and immune disorders and disease such as multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

ORGANIC COMPOUNDS

There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.